David Shaw’s Zimmer Biomet ZBH Stock Holding History

David Shaw’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,600	Closed	-$2.31M	–	5281
2026 Q1	$2.31M	Buy	+25,600	New	+$2.35M	﹤0.01%	2807
2014 Q4	–	Sell	-10,300	Closed	-$1.01M	–	4295
2014 Q3	$1.01M	Hold	10,300	–	–	﹤0.01%	2808
2014 Q2	$1.04M	Buy	+10,300	New	+$1M	﹤0.01%	2916
2014 Q1	–	Sell	-68,289	Closed	-$6.18M	–	4680
2013 Q4	$6.18M	Buy	68,289 +3,296	+5%	+$285K	0.01%	1509
2013 Q3	$5.18M	Buy	64,993 +26,780	+70%	+$2.11M	0.01%	1560
2013 Q2	$2.78M	Buy	+38,213	New	+$2.86M	0.01%	1815

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

David Shaw's ZBH Position: Q2 2026 in Review

David Shaw increased its Zimmer Biomet (ZBH) stake by 164% in Q2 2026, buying an estimated $1.31M and bringing the position to 24,120 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

David Shaw first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $156M in Q4 2015. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

David Shaw held 24,120 shares of Zimmer Biomet worth $2.08M as of Q2 2026.
David Shaw bought 14,974 Zimmer Biomet shares in Q2 2026, an estimated $1.31M.
Zimmer Biomet made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3171 holding.
David Shaw first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
David Shaw's Zimmer Biomet position peaked at $156M in Q4 2015.
904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.